Gillies Hunter's most recent trade in Jade Biosciences Inc was a trade of 6,000 Common Stock done at an average price of $24.5 . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.50 per share. | 13 Jun 2024 | 6,000 | 5,602 | - | 24.5 | 147,000 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 6,000 | 83,510 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 13 Jun 2024 | 6,000 | 11,602 | - | 2.1 | 12,840 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 17 May 2024 | 4,000 | 9,602 | - | 2.1 | 8,560 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 4,000 | 11,324 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 21.07 per share. | 17 May 2024 | 3,914 | 5,688 | - | 21.1 | 82,452 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 21.86 per share. | 17 May 2024 | 86 | 5,602 | - | 21.9 | 1,880 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 17 Apr 2024 | 4,000 | 7,251 | - | 1.7 | 6,960 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.30 per share. | 17 Apr 2024 | 3,689 | 3,562 | - | 22.3 | 82,267 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 3,497 | 539 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 503 | 2,511 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.33 per share. | 17 Apr 2024 | 311 | 3,251 | - | 23.3 | 7,255 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 9,000 | 89,510 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 28 Mar 2024 | 9,000 | 12,251 | - | 2.1 | 19,260 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 28 Mar 2024 | 9,000 | 3,251 | - | 29.5 | 265,500 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.81 per share. | 18 Mar 2024 | 6,387 | 3,864 | - | 25.8 | 164,872 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 4,000 | 4,036 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 18 Mar 2024 | 4,000 | 7,251 | - | 1.7 | 6,960 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 18 Mar 2024 | 3,000 | 10,251 | - | 2.1 | 6,420 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 3,000 | 98,510 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.40 per share. | 18 Mar 2024 | 613 | 3,251 | - | 26.4 | 16,185 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.50 per share. | 07 Mar 2024 | 8,975 | 3,251 | - | 24.5 | 219,888 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Mar 2024 | 8,975 | 12,226 | - | 2.1 | 19,207 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 8,030 | 101,510 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 945 | 15,324 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 23 Feb 2024 | 511 | 3,251 | - | 19.5 | 9,965 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 511 | 3,014 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 23 Feb 2024 | 511 | 3,762 | - | 1.7 | 889 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 20 Feb 2024 | 3,489 | 6,740 | - | 1.7 | 6,071 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 20 Feb 2024 | 2,591 | 4,149 | - | 20.1 | 52,097 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,502 | 3,525 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 987 | 8,036 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 20.58 per share. | 20 Feb 2024 | 898 | 3,251 | - | 20.6 | 18,478 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 66,586 | 66,586 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 17 Jan 2024 | 4,000 | 3,251 | - | 19.5 | 78,000 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 17 Jan 2024 | 4,000 | 7,251 | - | 1.7 | 6,960 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 4,000 | 6,027 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.50 per share. | 27 Dec 2023 | 125 | 3,251 | - | 24.5 | 3,063 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 27 Dec 2023 | 125 | 3,376 | - | 2.1 | 268 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 100 | 109,540 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 25 | 16,269 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 20 Dec 2023 | 4,000 | 7,251 | - | 1.7 | 6,960 | Common Stock |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 20 Dec 2023 | 4,000 | 3,251 | - | 19.5 | 78,000 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 2,924 | 9,023 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 1,076 | 10,027 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 13 Dec 2023 | 9,897 | 13,148 | - | 1.7 | 17,221 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 13 Dec 2023 | 9,897 | 3,251 | - | 19.5 | 192,992 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 7,197 | 10,306 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 2,700 | 12,744 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Gillies Hunter | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 13 Dec 2023 | 2,103 | 5,354 | - | 1.7 | 3,659 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 13 Dec 2023 | 2,103 | 3,251 | - | 19.5 | 41,009 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 1,450 | 17,503 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 653 | 15,444 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 19 May 2023 | 65 | 3,251 | - | 19.5 | 1,268 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 65 | 18,953 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 19 May 2023 | 65 | 3,316 | - | 1.7 | 113 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 17 May 2023 | 1,090 | 4,341 | - | 1.7 | 1,897 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,090 | 19,018 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.59 per share. | 17 May 2023 | 1,090 | 3,251 | - | 19.6 | 21,356 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 21 Apr 2023 | 4,000 | 1,960 | - | 19.5 | 78,000 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 4,000 | 20,108 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 21 Apr 2023 | 4,000 | 5,960 | - | 1.7 | 6,960 | Common Stock |
| Jade Biosciences Inc | Hunter Gillies | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 62,000 | 62,000 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 65,433 | 65,433 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 109,640 | 109,640 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 60,300 | 60,300 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Hunter Gillies | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 16,294 | 16,294 | - | - | Stock Option (Right to Buy) |